This article was originally published in The Tan Sheet
Elder makes Max move into OTCs; Nutrient Synergy draws drug claim warning; Sibutramine-spiked product recalled; Provexis plans cuts to maximize FruitFlow profits; DSM adds New Zealand premix firm; drug interaction tool for smartphones; more news In Brief.
You may also be interested in...
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.
Galapagos and Gilead's JAK inhibitor has been approved for rheumatoid arthritis in the second and third biggest pharma markets, softening the blow somewhat of rejection from the US FDA in the biggest market last month.
American Injectables plans to build up its US-based manufacturing after securing a commitment for $10m of ‘Series A’ financing from New Rhein Healthcare Investors, which it will use to scale up production and launch several generic parenteral products.